公开报告
公开研究报告
由运营明确公开发布到本站的多智能体研究报告。每份都有分析日期与投资组合经理最终评级。仅供研究参考,不构成投资建议,也不执行交易。
来自投资组合经理的五档最终评级,不是交易员的中间动作。
- 持有
Coca-Cola Company
KONYSEHold current position with tighter $85.00 stop-loss and wait for $92.00+ breakout with momentum confirmation before reassessing exposure.
分析日期2026-09-02
分析语言英语
报告数量1 份
阅读报告 - 持有
Wells Fargo & Company
WFCNYSEHold current position in Wells Fargo & Company (WFC) pending confirmation at key technical levels.
分析日期2026-09-02
分析语言英语
报告数量1 份
阅读报告 - 持有
Salesforce, Inc.
CRMNYSEHold current position with disciplined risk management: tighten stop to $268 and take partial profits at $260–$265.
分析日期2026-09-02
分析语言英语
报告数量1 份
阅读报告 - 减持
System1, Inc. Class A
SSTNYSEReduce existing exposure to minimal or zero position by end of Q3 2026; do not add under any circumstance.
分析日期2026-09-01
分析语言英语
报告数量1 份
阅读报告 - 持有
Caterpillar Inc.
CATNYSEHold current position; wait for technical breakout above $890.14 and fundamental confirmation of Power & Energy execution before increasing exposure.
分析日期2026-08-31
分析语言英语
报告数量1 份
阅读报告 - 持有
GE Vernova Inc.
GEVNYSEHold current position in GEV pending decisive technical or fundamental confirmation.
分析日期2026-08-31
分析语言英语
报告数量1 份
阅读报告 - 持有
Becton, Dickinson and Company
BDXNYSEHold current position with tightened stop at $174.0 and conditional hedge; await resolution of FDA remediation, Phasix data, and Q4 earnings.
分析日期2026-08-21
分析语言英语
报告数量1 份
阅读报告 - 持有
American States Water Company
AWRNYSEHold current position with a tightened stop-loss at $87.00, awaiting confirmation from Q3 earnings, FCF improvement, and 10Y yield movement.
分析日期2026-08-21
分析语言英语
报告数量1 份
阅读报告 - 持有
Merck & Co., Inc.
MRKNYSEHold current MRK position pending de-risking catalysts such as FDA filing confirmation, REGAL AML data, or commercial launch clarity.
分析日期2026-08-21
分析语言英语
报告数量1 份
阅读报告 - 持有
Bank of America Corp
BACNYSEHold current position in Bank of America Corp (BAC), awaiting resolution of India credit quality and AI project viability before adjusting exposure.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告 - 持有
AbbVie, Inc.
ABBVNYSEHold current position in ABBV pending resolution of the A-327 FDA decision and confirmation of sustained free cash flow generation.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告 - 持有
Johnson & Johnson
JNJNYSEHold current position, using $266.00 as a dynamic stop-loss and awaiting Q3 earnings and Monarch adoption data for confirmation.
分析日期2026-08-19
分析语言英语
报告数量2 份
阅读报告 - 持有
Mastercard Incorporated Class A
MANYSEHold current position in MA; maintain neutral sizing while monitoring $559 support and $599 resistance for directional confirmation.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告 - 持有
Exxonmobil Holdings Corporation
XOMNYSEMaintain current XOM position; no addition or reduction warranted at this time.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告 - 增持
Visa Inc. Class A
VNYSEOverweight Visa (V) gradually across three tranches, using pullbacks as tactical opportunities while respecting near-term resistance and regulatory risk.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告 - 增持
JPMorgan Chase & Co.
JPMNYSEGradually increase long exposure to JPM with disciplined entry and dynamic risk controls.
分析日期2026-08-19
分析语言英语
报告数量2 份
阅读报告 - 增持
Eli Lilly and Company
LLYNYSEOverweight LLY with disciplined, phased accumulation: initiate 25% at $1,280, add 25% at $1,300, and 25% at $1,350 — stop-loss at $1,150.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告 - 持有
Berkshire Hathaway Inc. Class A
BRK.ANYSEHold current position in BRK.A, using $745,000 and $795,000 as key price-based review triggers.
分析日期2026-08-19
分析语言英语
报告数量1 份
阅读报告